Introduction
Reversible phosphorylation of tyrosine residues in proteins plays a central role in regulation of cellular function, and is controlled through the opposing activities of protein tyrosine kinases (PTKs) and -phosphatases (PTPases) (reviewed in Sun and Tonks, 1994; Hunter, 1995) . Links between abnormal PTK activity, aberrant tyrosine phosphorylation, and a wide range of physiological phenomena are now well established, suggesting roles of similar importance for PTPases. Despite signi®cant advances in cloning PTPases and in understanding their physiological roles during the past decade (reviewed in Neel and Tonks, 1997) , large gaps exist at present in our understanding of the precise details of the physiological functions of most PTPases.
PTPases are a structurally diverse family of transmembranal, receptor-like and non-transmembranal, cytoplasmic enzymes, of which several dozen individual members have been identi®ed in organisms ranging from viruses to man (reviewed in Barford et al., 1995; Tonks and Neel, 1996) . Transmembranal PTPases typically contain two catalytic domains each, and are believed to bind extracellular molecules and participate in transducing signals across the cellular membrane. Cytoplasmic PTPases generally contain a single PTPase catalytic domain¯anked by protein domains which regulate the activity of the molecule in some cases (Hao et al., 1997; Barford and Neel, 1998) , or target it to particular regions within the cell in others (reviewed in Mauro and Dixon, 1994) . PTPases of this class, generally those containing SH2 domains, have been found in association with transmembranal receptor molecules. Depending on the particular case, this association can enhance or decrease the intensity of the transduced signal and is physiologically signi®cant (reviewed in Feng and Pawson, 1994; Barford et al., 1995; Imboden and Koretsky, 1995) . Not surprisingly, several key members of this diverse family of enzymes have been implicated in control of growth, dierentiation and malignant transformation (Tonks and Neel, 1996) . Nonetheless, many signi®cant molecular details of PTPase activity are lacking.
The signi®cant role tyrosine phosphorylation plays in malignant transformation prompted us to study the involvement of PTPases in the genesis of breast cancer in transgenic mice, which develop mammary tumors due to breast-speci®c expression of oncogenes directed by the Mouse Mammary Tumor Virus (MMTV) promoter (Sinn et al., 1987; Muller et al., 1998) . These studies have revealed that expression of the receptor-type transmembranal PTPase Epsilon (tmPTPe) is enhanced speci®cally in murine mammary tumors initiated by ras or neu, but not by c-myc, int-2, heregulin, or TGFa (Elson and Leder, 1995a; AE, unpublished results) . This result suggests that a mechanistic connection may exist between PTPe activity and mammary transformation by these two oncogenes. A second form of PTPe, known as cytoplasmic PTPe (cyt-PTPe), exists and diers from tm-PTPe only at its extreme amino terminus (Elson and Leder, 1995b) . Both forms of PTPe are products of a single gene, but their disparate expression patterns suggest that each has a distinct physiological function (Elson and Leder, 1995b; Elson et al., 1996; Tanuma et al., 1999) .
PTPe was ®rst cloned from human placenta by Saito and co-workers (Krueger et al., 1990) . In recent years tm-PTPe has been implicated in down-regulation insulin receptor signaling (Moller et al., 1995) and possibly in osteoclast function (Schmidt et al., 1996) and cerebellar development (Mukouyama et al., 1997) , in addition to its suggested involvement in transforma-tion of mammary epithelial cells. Cyt-PTPe is expressed almost exclusively in hematopoietic tissues, suggesting that its physiological role may lie there (Elson and Leder, 1995b) . However, few molecular-level details have emerged to explain the role of PTPe in cellular physiology. We believe that insight into this issue can be gained by positioning PTPe in speci®c signal transduction pathways; we have therefore chosen to study this issue by identifying molecules with which PTPe associates, and stimuli which aect these associations.
The present study focuses on interactions between PTPe and the adaptor molecule Grb2, as PTPe contains ®ve tyrosine residues which conform to the consensus sequence to which Grb2 binds. Furthermore, Grb2 has been shown to bind protein tyrosine phosphatase a (PTPa), a close structural relative of PTPe (den Hertog et al., 1994; den Hertog and Hunter, 1996; Su et al., 1994 Su et al., , 1996 . We demonstrate here that transmembranal and cytoplasmic PTPe can bind Grb2 in vivo and in vitro. Binding is mediated by the SH2 domain of Grb2 and the carboxy-terminal tyrosine of cyt-PTPe; Grb2 binds tm-PTPe also at additional phosphotyrosine residues. Signi®cantly, tm-PTPe can associate constitutively with Grb2 in mouse mammary tumors initiated by neu or ras, and cyt-PTPe binds Grb2 in Jurkat T-cells following stimulation of T-cell receptor signaling by pervanadate, hinting at possible physiological roles for this interaction.
Results

Transmembranal and cytoplasmic forms of PTPe bind Grb2 in vivo
In order to determine whether PTPe and Grb2 can associate in vivo we studied 293T cells transiently expressing either transmembranal or cytoplasmic PTPe of mouse origin. Following cell lysis, endogenous Grb2 and proteins which bound to it were immuneprecipitated with anti-Grb2 antibodies and analysed for presence of associated PTPe (Figure 1a and b) . In some cases transfected cells were cultured immediately prior to lysis in the presence of the PTPase inhibitor sodium pervanadate (Hecht and Zick, 1992; Huyer et al., 1997) . Inhibition of cellular PTPases in vivo increases tyrosine phosphorylation of PTPe (AE and Zohar Tiran, unpublished results), as well as of other cellular proteins. Pervanadate-treated cells were included in the study to assess the possible role of tyrosine phosphorylation in interactions between PTPe and Grb2.
tm-PTPe was present in cellular extracts as two major full-length protein species which dier in their glycosylation pattern (Elson and Leder, 1995a) . A minor *70 kDa PTPe-derived protein was also detected in transfected cells and mammary tumors used in this work. Tm-PTPe was detected in immuneprecipitates of Grb2 from freely-growing cells, indicating that a basal level of association exists between the two molecules ( Figure 1a, top panel) . Inhibition of PTPase activity in the cells prior to lysis signi®cantly increased the amount of PTPe associated with Grb2, indicating that phosphorylation of tyrosine residues in PTPe plays an important role in mediating this interaction (Figure 1a) . Similar results were obtained in cells which overexpressed cyt-PTPe (Figure 1b ).
Grb2 and PTPe were co-immunoprecipitated also when anti-PTPe serum was the precipitating agent. Although the polyclonal anti-PTPe antiserum used here (Elson and Leder, 1995a) does not precipitate PTPe eciently, some PTPe-associated Grb2 was detected in these experiments (Figure 1c) . Pretreatment of cells with sodium pervanadate signi®cantly increased the amount of Grb2 detected in immunoprecipitates of tm-PTPe, but not in control experiments in which PTPe was not expressed (Figure 1c) , or in which the precipitating agent was pre-immune serum (not shown). Similar results were obtained in cells overexpressing cyt-PTPe (Figure 1d) . These experiments indicate that either form of PTPe can associate in vivo with Grb2 in a largely phosphotyrosinedependent manner.
Binding of Grb2 to PTPe is mediated by the SH2 domain of Grb2
In order to determine which functional domains of Grb2 mediate binding to PTPe, we performed in vitro precipitation experiments in which bacterially-produced glutathione-S-transferase (Gst) fusion proteins containing various domains of Grb2 were separately added to lysates of PTPe-expressing cells. Following incubation, Gst-Grb2 fusion proteins were subject to immunoblot analysis to determine whether they had bound PTPe. In addition to Gst fusions of full-length, wild-type Grb2, these experiments made use of Gst fusions of isolated N-SH3, SH2, or C-SH3 domains of Grb2, or of fusions of full-length Grb2 in which inactivating point mutations had been introduced into the N-SH3 (Grb2-P49L), SH2 (Grb2-R86K), or C-SH3 (Grb2-G203R) domains.
Full-length, unmutated Gst-Grb2 bound and precipitated either tm-or cyt-PTPe molecules expressed in 293T cells, indicating that binding of Grb2 to PTPe could be recapitulated in this system (Figure 2 ). Of the isolated domains of Grb2, the Gst-SH2 fusion protein bound either form of PTPe while Gst-N-SH3 and Gst-C-SH3 fusions did not. In agreement with these results, full-length Grb2 proteins which were mutated in either their N-SH3 or C-SH3 domains, but retained an unmutated SH2 domain, bound PTPe strongly. Inactivation of the SH2 domain of Grb2 prevented binding of Grb2 to PTPe, indicating that this domain is crucial in binding PTPe ( Figure 2 ). These results con®rm the central role of the SH2 domain of Grb2 in mediating binding to both forms of PTPe.
Phosphorylation of the PTPe C-terminal tyrosine is sucient to allow Grb2 binding in vitro
The phosphotyrosine-dependent portion of interactions which bind PTPa to Grb2 is mediated mainly by a single tyrosine residue located near the carboxyterminal of PTPa (Y789 or Y798 of mouse or human PTPa, respectively; den Hertog et al., 1994; den Hertog and Hunter, 1996; Su et al., 1994 Su et al., , 1996 . This tyrosine residue is conserved as Y638 in cyt-PTPe and as Y695 in tm-PTPe; surrounding amino acid residues are conserved as well ( Figure 3a) . In order to determine whether phosphorylation of this single tyrosine residue is sucient to mediate binding of PTPe to Grb2, we attempted to precipitate endogenous Grb2 from cell lysates using a peptide derived from PTPe which included the C-terminal tyrosine as its only tyrosine residue. This peptide, which contained the last 11 carboxy-terminal amino acids of PTPe (IDIFS-DYANFK, identical in both forms of PTPe), was produced as a Gst fusion protein in bacteria (Gst-e-tail/ Y695, numbering as in tm-PTPe).
Gst-e-tail/Y695 protein was produced and tyrosinephosphorylated in vivo in TKB1 bacteria, which express an exogenous tyrosine kinase of broad substrate speci®city (Figure 3b ). For control experiments, a mutated Gst-e-tail/Y695F protein, in which Y695 was replaced by an unphosphorylatable phenylalanine residue, was similarly prepared. Strong phosphorylation of the Gst-e-tail/Y695F protein, in which the PTPe-derived region lacks tyrosine residues, indicated that some of the 14 residues of the Gst protein itself were also phosphorylated in TKB1 bacteria ( Figure 3b ). Gst-e-tail proteins were not phosphorylated in BL26 bacteria, which lack tyrosine kinase activity ( Figure 3b) .
In order to determine whether phosphorylated Y695 could mediate binding to Grb2 on its own, tyrosinephosphorylated Gst-e-tail/Y695 protein was added to lysates of a mouse mammary tumor cell line induced by neu (SMF cells; Muller et al., 1988) . As seen in Figure 3c , Grb2 indeed bound phosphorylated Gst-etail/Y695 and was precipitated by it. Binding was Figure 2 The SH2 domain of Grb2 mediates binding to transmembranal (e-TM) or cytoplasmic (e-CYT) PTPe. Lysates of pervanadate-treated 293T cells, transiently transfected with either form of PTPe, were precipitated with Gst fusion constructs containing full length Grb2 or isolated domains thereof. Domains inactivated by point mutations in Grb2 mutants are crossed out. Precipitates were analysed by protein blotting with anti-PTPe antibodies. Equal recovery of Gst fusion proteins from the various precipitations was veri®ed by Coomassie Brilliant Blue staining Figure 3 The phosphorylated C-terminal tyrosine of PTPe is sucient to mediate binding to Grb2. (a) Comparison of the amino acid sequence at the C-terminal end of mouse tm-PTPe, cyt-PTPe and PTPa. The terminal tyrosine and the Grb2 recognition sequence are underlined. The C-terminal ends of the proteins are marked by an asterisk. (b) Tyrosine phosphorylation status of Gst-e-tail constructs before (top panel) and after (middle panel) incubation with lysates of SMF (neu-initiated murine mammary adenocarcinoma) cells. Gst-e-tail proteins were grown in TKB1 (tyrosine kinase +) or BL26 bacteria (tyrosine kinase 7) bacteria. Recovery of Gst fusion proteins from cell lysates is veri®ed by a Coomassie stain of the gel (bottom panel). (c) Gst-e-tail can precipitate endogenous Grb2 from lysates of SMF cells; bound Grb2 was detected by SDS ± PAGE and immunoblotting with anti-Grb2 antibodies dependent on phosphorylation of Y695, as Grb2 did not bind the same protein prepared in unphosphorylated form, nor to the phosphorylated Y695F version of this protein grown in TKB1 bacteria (Figure 3c ). This last control was especially important as it indicated that Y695 of PTPe, and not any of the phosphorylated tyrosine residues present in the Gst portion of the fusion molecule, was the binding site for Grb2. Of note, binding of cellular proteins to phosphorylated Y695 was strong enough to protect this residue from dephosphorylation by PTPases present in the cell lysate (Figure 3b) . Overall, these results indicate that phosphorylation of the C-terminal tyrosine of PTPe is sucient to allow binding of Grb2, and that absence of other tyrosine residues of PTPe or of possible binding sites for Grb2/SH3 domains do not prevent this interaction.
Grb2 binds dierent sites in transmembranal and in cytoplasmic PTPe
In order to determine whether the C-terminal tyrosine of PTPe mediates binding of Grb2 to PTPe in the context of the whole PTPe protein, we mutated this residue to an unphosphorylatable phenylalanine (Y638F and Y695F in cyt-and tm-PTPe, respectively). Following expression of these or of unmutated, wild-type PTPe proteins in 293T cells, the mutated form of cyt-PTPe could not bind Gst-Grb2 (Figure 4 , left panel). Similarly, no binding was observed also following hyperphosphorylation of PTPe by incubation of cells before lysis with sodium pervanadate. This ®nding indicates that Y638 is the exclusive site in cytPTPe to which the SH2 domain of Grb2 binds. In contrast, wild-type (Y695) or mutant (Y695F) tm-PTPe bound Grb2 to similar extents (Figure 4, right panel) . In vitro binding experiments using the panel of GstGrb2 proteins described previously in this work indicated that Grb2 bound PTPe/Y695F through the Grb2/SH2 domain (results not shown). This suggests that the SH2/Grb2 domain binds additional tyrosine residues in tm-PTPe, possibly including but not limited to Y695. Of note, both isoforms of PTPe contain four additional tyrosine residues in sequence contexts which ®t the Grb2 binding consensus (pYXNX) and which could serve as alternative sites for Grb2 binding.
The SH3 domains of Grb2 do not bind PTPe
The C-terminal SH3 domain of Grb2 has been shown to bind PTPa, a close structural relative of PTPe (den Hertog and Hunter, 1996; Su et al., 1996) . Although our results do not indicate that the SH3 domains of Grb2 participate in binding PTPe, we re-examined this issue by determining whether PTPe and Grb2 could associate in the absence of SH2 phosphotyrosine (SH2-pTyr) interactions. As the SH2-pTyr interactions between cyt-PTPe and Grb2 in 293T cells can be blocked by the Y638F mutation (Figure 4) , we used the PTPe/Y638F mutant in this series of experiments and, in order to further reduce tyrosine phosphorylation in PTPe, did not treat cells or lysates with sodium pervanadate.
Interactions between unphosphorylated cyt-PTPe/ Y638F and Grb2 were examined in vitro using the panel of full-length, mutated Gst-Grb2 fusion molecules. Existence of signi®cant interactions between SH3 domain(s) of Grb2 and PTPe should drive association between PTPe and Grb2 molecules which have intact SH3 domains, such as wild-type Grb2 or the SH2 mutant (Grb2-R86K). On the other hand, in the absence of SH3-based interactions PTPe/Y638F should not bind any of the four types of Grb2 molecules used as it lacks the tyrosine docking site for the Grb2/SH2 domain. In agreement with this second scenario, unphosphorylated cyt-PTPe/Y638F did not bind any of the four types of Grb2 molecules used ( Figure 5 ). The Grb2 proteins used here were functional as they precipitated phosphorylated, wildtype cyt-PTPe/Y638 in a manner similar to that demonstrated previously (Figures 2, 4 and 5) . These results indicate that signi®cant direct SH3-based interactions between cyt-PTPe and Grb2 do not occur in 293T cells.
As Grb2 is often found in association with the guanine-nucleotide exchange factor SOS, we asked whether SOS is associated with the PTPe-Grb2 complex in 293T cells. Experiments addressing this point included precipitation of SOS using anti-SOS antibodies or a Gst-SOS pull-down experiment, followed by protein blot analysis to determine whether Grb2 and PTPe were among the precipitated proteins. Although Grb2 was routinely precipitated in these experiments, the results for either form of PTPe were inconclusive (not shown), possibly indicating that only a little, if any, PTPe-bound Grb2 binds SOS.
Grb2 constitutively binds tm-PTPe in ras-or neu-induced mammary tumor cells
We next asked whether Grb2 could associate with endogenous PTPe in non-transfected cells which express this PTPase as part of their cellular complement of proteins. tm-PTPe is strongly expressed in mouse mammary tumors initiated by ras or neu (Elson and Leder 1995a) . In order to determine whether PTPe from these cells could associate with Grb2 we subjected lysates of AC816 cells (ras-initiated mouse mammary tumor cells; Leder et al., 1990) , to in vitro binding with Figure 4 Grb2 binds dierent repertoires of phosphotyrosine residues in cyt-vs tm-PTPe. Left panel: Lysates of pervanadatetreated 293 cells expressing either wild-type (Y638) or Y638F mutant cyt-PTPe were precipitated with Gst-Grb2. Presence of bound PTPe was assayed by protein blotting with anti-PTPe antibodies (top panel). Equal expression of cyt-PTPe was veri®ed by protein blot analysis with anti-PTPe antibody (middle panel); equal recovery of Gst-Grb2 from lysates ws veri®ed by Coomassie staining of the gel (bottom panel). Right panel: Similar analysis using cells expressing tm-PTPe, indicating that the parallel Y695F mutation does not prevent Grb2 from binding this form of PTPe the series of Gst-Grb2 fusion proteins described previously. Binding of Grb2 to tm-PTPe was easily detected in freely-growing AC816 cells (Figure 6a ). Here too, the Grb2/SH2 domain was critical in mediating binding to tm-PTPe while the Grb2/SH3 domains did not appear to play a detectable role in mediating this interaction (Figure 6a ). In agreement with these results, pre-treatment of AC816 cells with sodium pervanadate increased somewhat the extent of this association (results not shown). Based on the relative amounts of PTPe protein present in AC816 cells and on the intensities of the signals obtained we estimate that on the order of 10-15% of PTPe can associate with Grb2 in these cells in the absence of pervanadate treatment. Similar results were obtained with SMF cells (neu-initiated mammary tumor cells; not shown). These results indicate that a basal level of association can exist between endogenous tm-PTPe and Grb2 in mammary tumor cells, most likely due to basal tyrosine phosphorylation of PTPe in these cells.
Grb2 is induced to bind cyt-PTPe in TCR-stimulated Jurkat T-cells
Cytoplasmic PTPe is most strongly expressed in mouse lymph nodes, thymus, and spleen, suggesting that the physiological function of this form of PTPe may be linked to the hematopoietic system (Elson and Leder, 1995b) . In order to address this possibility we turned to Jurkat T cells, which respond to T-cell receptor (TCR) stimulation with a series of molecular events believed to recapitulate steps which follow TCR stimulation in non-malignant T-cells. Preliminary experiments revealed that freely-proliferating Jurkat cells constitutively express cyt-PTPe (Figure 6b ). In vitro precipitation experiments using the Gst-Grb2 fusion protein revealed that cyt-PTPe cannot associate with Grb2 in freely-proliferating Jurkat cells. In contrast, cyt-PTPe could associate with Grb2 in lysates of Jurkat cells which had been brie¯y treated with pervanadate, an agent known to be a strong stimulant of TCR signaling in these cells (Secrist et al., 1993; Imbert et al., 1994) ( Figure 6b ). These results suggest that cyt-PTPe can be recruited to form a complex with Grb2 in the course of T-cell activation and indicate that cyt-PTPe may play a role in regulating this process.
Discussion
Despite recent signi®cant advances in understanding the physiological functions of speci®c PTPases, the role many members of this family play in cellular physiology remain poorly understood. We have chosen to study the physiological role of PTPe by identifying molecules which interact with this enzyme; their signi®cant potential for dynamic regulation has made phosphotyrosine-mediated interactions the focus of our present study.
One of the better-known molecules which interacts with phosphotyrosine residues is Grb2, a ubiquitouslyexpressed molecule comprised of one SH2 and two SH3 domains. Although devoid of enzymatic activity, Grb2 is a central mediator of signal transduction as its binding to activated receptors can translocate SOS to the cellular membrane, thereby activating Ras and other downstream signaling molecules (Li et al., 1993; Olivier et al., 1993; Rozakis-Adcock et al., 1993) . Several non-receptor PTPases bind Grb2, among them SHP1 (Kon-Kozlowski et al., 1996) , SHP2 (Tauchi et al., 1994 (Tauchi et al., , 1995 Tailor et al., 1996) , and MPTP-PEST (Charest et al., 1997) . SHP2 has been shown to bind both the PDGF receptor and Grb2, in eect linking the receptor to the Grb2/SOS complex in a manner regulated by receptor activation (Li et al., 1994; Bennett et al., 1994; Vogel and Ullrich, 1996) . Receptor-type PTPases, such as CD45 (Lee et al., 1996) , and PTPa (den Hertog et al., 1994; den Hertog and Hunter, 1996; Su et al., 1994 Su et al., , 1996 also bind Grb2. The physiological role binding of Grb2 to PTPases plays is for the most part not clear and may vary from case to case. In addition to linking receptor molecules to the Grb2/SOS complex, binding to Grb2 has been suggested to recruit substrates for PTPases, recruit cytoplasmic PTPases to transmembranal receptor molecules as part of up-or down-regulation of receptor-mediated signaling, regulate PTPase activity, or in¯uence Grb2 activity by preventing Grb2 binding other molecules.
Our results indicate that both forms of PTPe can associate with Grb2 in vivo and in vitro. Phosphotyrosine-SH2 interactions in and of themselves are sucient to mediate binding of Grb2 to PTPe. This is demonstrated by the abilities of an isolated Grb2/ SH2 domain to bind cellular PTPe, and of a short PTPe-derived peptide containing the phosphorylated Cterminal tyrosine of PTPe to precipitate Grb2 from cell lysates. Furthermore, full-length Grb2 containing an inactivated SH2 domain cannot bind PTPe, indicating that both Grb2/SH3 domains cannot compensate for lack of a functional SH2 domain. In contrast, Grb2 molecules containing inactivated SH3 domains are able to bind PTPe, so long as they retain a functional SH2 domain. The data strongly suggest that Grb2 binding of PTPe is direct and not mediated by an intermediary molecule. PTPe does not appear to bind the guaninenucleotide exchange factor SOS. The PTPe-Grb2 complex may therefore serve to sequester Grb2 or to recruit other Grb2-binding molecules to the vicinity of the phosphatase.
The C-terminal tyrosine residue of PTPe plays an important role in mediating interactions between Grb2 and PTPe, much as it does in binding of Grb2 to the related PTPa (den Hertog et al., 1994; den Hertog and Hunter, 1996; Su et al., 1996) . Our results show that this tyrosine, Y638 in cyt-PTPe, is the only Grb2 docking site in this form of PTPe; mutating Y638 to a phenylalanine prevents binding of Grb2 to cyt-PTPe. On the other hand, Grb2 binds the analogous mutant of tm-PTPe (Y695F), indicating that phosphorylation of this tyrosine residue is not a prerequisite for Grb2 binding. As binding of Grb2 to tm-PTPe is nonetheless mediated by the SH2 domain of Grb2, it is likely that Grb2 binds one or more of the other tyrosine residues in tm-PTPe, thereby bypassing the eects of the Y695F mutation. tm-PTPe contains 22 tyrosine residues of which ®ve ( 164 YPNI, 188 YINA, 255 YGNI, 480 YINA, and 695 YANF) appear in the amino acid context recognizable by the SH2 domain of Grb2 (pYXNX, Songyang et al., 1994) . Our Gst-precipitation experiments do indicate, however, that phosphorylated Y695 is capable of serving as a docking site for Grb2 (Figure 3) .
Of note, both tm-and cyt-PTPe share most of their amino acid sequences, including all ®ve tyrosines which ®t the consensus for Grb2/SH2 binding. Why then does Grb2 bind a single phosphotyrosine in cyt-PTPe while binding more promiscuously to tm-PTPe? Their dierent subcellular localizations (Elson and Leder, 1995b) suggest that each form of PTPe encounters dierent PTKs and other interacting molecules. Each form of PTPe is likely then to be phosphorylated at dierent tyrosine residues, thereby creating distinct docking sites for Grb2. As dierent types of cells express dierent repertoires of PTKs, the relative importance of each of the potential docking sites for Grb2 in either form of PTPe may vary among cell types.
tm-and cyt-PTPe can bind Grb2 also in cells which normally express PTPe. We show here that tm-PTPe can bind Grb2 in freely-growing mouse mammary tumor cells initiated speci®cally by neu or ras in a manner dependent on phosphotyrosine-SH2 interactions. It is therefore attractive to speculate that activated tyrosine kinase molecules adjacent to tm-PTPe phosphorylate PTPe, thereby linking this phosphatase to downstream molecules which H6Lp transduce signals across the cellular membrane. Indeed co-expression of tm-PTPe and neu in 293T cells increases both tyrosine phosphorylation of PTPe and its association with Grb2 (AE and Zohar Tiran, unpublished results). These ®ndings are consistent with the suggestion that a functional link exists between PTPe expression and transformation of mammary epithelial cells by ras or neu (Elson and Leder, 1995a) .
The ®nding that cyt-PTPe can be induced to associate with Grb2 in Jurkat T-cells following stimulation by pervanadate suggests that a similar situation may exist with respect to this form of PTPe as well. Although the T-cell receptor lacks inherent enzymatic activity, tyrosine phosphorylation plays a critical role in mediating events which follow TCR stimulation (reviewed in Howe and Weiss, 1995; Qian and Weiss, 1997) . Few PTPases have been shown to participate in this process (reviewed in Neel, 1997) . The best known of these is the receptor-type PTPase CD45, which plays a vital role in TCR signaling in part by dephosphorylating and activating Lck and Fyn in the initial steps following receptor activation (reviewed in Frearson and Alexander, 1997) . The results presented here suggest that cyt-PTPe may be linked to signaling events in T-cells, although the molecular details of this involvement remain to be elucidated.
Despite their structural similarities, PTPe and PTPa bind Grb2 in somewhat dierent manners. The Grb2/ C-SH3 domain participates in binding PTPa in an indirect manner (den Hertog and Hunter, 1996; Su et al., 1996) ; in contrast, we have found no evidence for participation of Grb2/SH3 domains in binding PTPe. Furthermore, the central role of the C-terminal tyrosine of PTPa in binding Grb2 is better paralleled by cytoplasmic, but not transmembranal, PTPe, although no cytoplasmic form of PTPa has been described. Additional dierences between PTPe and PTPa exist, including in the relative activities of their two catalytic domains (Wang and Pallen, 1991; Lim et al., 1997; Wu et al., 1997) . tm-PTPe is expressed speci®cally in mouse mammary tumors initiated by ras or neu, while PTPa expression is not strictly correlated with the identity of the transforming oncogene (Elson and Leder, 1995a) . Taken together, these dierences further indicate that despite their signi®cant structural similarities, PTPa and PTPe may each have distinct physiological roles.
Materials and methods
Cell lines and tissue culture SMF (Muller et al., 1988) and AC816 (Leder et al., 1990) are murine mammary epithelial cell lines isolated from mammary tumors of mice transgenic for neu or ras, respectively. Cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM, Sigma), supplemented with 10% (vol/vol) iron-supplemented bovine serum (Hyclone). Human kidney 293T cells were grown in DMEM supplemented with 10% newborn calf serum (GIBCO/BRL), while Jurkat cells were grown in RPMI medium supplemented with 10% fetal calf serum (GIBCO/BRL). All media were supplemented with 2 mM glutamine, 50 units/ml of penicillin and 50 mg/ml of streptomycin.
Bacterial and eukaryotic expression constructs
The complete coding region of tm-PTPe (cDNA clone 58 from mouse brain; Elson and Leder, 1995a) was isolated by digestion with SmaI and XhoI and subcloned into the EcoRV and XhoI sites of pCDNA3 (Invitrogen). Cytoplasmic PTPe cDNA (Elson and Leder 1995b ) was ampli®ed by PCR using Vent polymerase (New England Biolabs) and the oligomers Eshort/Nhe (GGGCTAGCATGAGCAGCAGAAAGAAC, sense strand) and Y695/Nhe (GGGCTAGCTCATTTGA-AATTAGCATA, antisense). The ampli®cation products were cleaved with NheI and subcloned into the compatible XbaI site of pCDNA3. The Y695F mutant of tm-PTPe was constructed by PCR ampli®cation of the tm-PTPe cDNA using oligomers Elong/Nhe (TTGCTAGCATGGAGCC-CTTCTGTCC, sense) and Y695F/Nhe (GGGCTAGCT-CATTTGAAATTAGCAAAATCAGAAAA, antisense); the latter oligomer introduces the Y695F mutation. The Y638F mutant of cytoplasmic PTPe was constructed in a similar manner, using oligomer Eshort/Nhe instead of Elong/Nhe. The presence of the desired mutations was veri®ed by DNA sequencing.
Gst-e-tail/Y695 construct was prepared by annealing the two complementary oligomers 20072 (GATCCATCGATA-TATTTTCTGATTATGCTAATTTCAAATG, sense strand) and 20073 (AATTCATTTGAAATTAGCATAATCAGAA-AATATATCGATG, antisense). The resulting doublestranded DNA fragment, which encoded the 11 C-terminal amino-acid residues of PTPe (IDIFSDYANFK), was cloned into the BamHI and EcoRI sites of pGEX2TK (Pharmacia). The mutated Gst-e-tail/Y695F construct was prepared in a similar manner using oligos 21884 (GATCCATCGATATA-TTTTCTGATTTTGCTAATTTCAAATGAG) and 21885 (AATTCTCATTTGAAATTAGCAAAATCAGAAAATAT-ATCGATG). The structure of the constructs was veri®ed by DNA sequencing.
Gst-Grb2 fusion constructs were generous gifts of Dr Thomas M Roberts, Dana-Farber Cancer Institute (full length wild-type Grb2, isolated N-SH3, SH2, and C-SH3 domains); Dr Yosef Yarden, The Weizmann Institute (full length wild-type Grb2), and Dr Jan Sap, New York University (full length wild-type Grb2 and the Grb2 point mutants P49L, R86K, G203R). The Gst-C-SOS construct was generated by subcloning the C-terminal region of the human SOS1 cDNA (nucleotides 3200 ± 4003), generously provided by Dr Ami Aronheim of the Technion, Israel Institute of Technology, into pGEX2TK.
Gst fusion constructs were grown in BL21 or BL26 bacteria and on occasion in tyrosine phosphorylated form in TKB1 bacteria (Stratagene), and bound to glutathioneSepharose beads (Pharmacia). The quality of each preparate was veri®ed by SDS ± PAGE analysis of an aliquot of beads. Tyrosine phosphorylation of Gst-e-tail constructs was checked by protein blotting using monoclonal antiphosphotyrosine antibodies (clone PY20, Transduction Laboratories).
Transfection and stimulation studies
Transient transfection of 293 cells was by the BES-calcium phosphate technique (Chen and Okayama, 1987) . Five mg supercoiled plasmid DNA were used to transfect each 30%-con¯uent 9' plate of cells split the day before. 15 ± 24 h after transfection, cells were washed twice in phosphate-buered saline and lysed in 500 microliters/9' plate of lysis buer A (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1% NP40, 1 mM sodium pervanadate, 0.5 mM phenymethylsulfonyl-¯uoride, 0.5 mg/ml leupeptin, 0.7 mg/ml pepstatin). Following 5 min incubation on ice, lysates were spun at 10 000 g for 10 min; an aliquot of the supernatant was saved for analysis and the rest was precipitated as described below. On occasion, cells were treated for 15 min before lysis with 0.15 mM sodium pervanadate; pervanadate stock solution was freshly prepared by mixing 300 ml of 50 mM sodium metavanadate (Sigma) with 1.5 ml of 30% hydrogen peroxide.
Precipitation studies
Immunoprecipitation studies were performed by mixing 500 ml of cell lysates containing equal amounts of protein (400 ± 800 mg) with either 1 mg rabbit polyclonal anti-Grb2 antibodies (Santa Cruz) or 1 ml polyclonal anti-PTPe antiserum (Elson and Leder 1995a) . Following 8 ± 15 h of gentle mixing at 48C in the presence of protein-A Sepharose beads (Pharmacia), beads were collected by centrifugation and washed four times in lysis buer A. Immunoprecipitates were analysed by SDS ± PAGE and protein blotting as described (Elson and Leder, 1995a) , using monoclonal antiGrb2 (Transduction Laboratories) or the polyclonal antiPTPe serum described above. In the latter case, the secondary detection reagent was horseradish-peroxidase-conjugated protein A. For Gst precipitation studies equal amounts of Gst fusion proteins, conjugated to glutathione-agarose beads, were added to lysates, incubated for 3 h at 48C with gentle mixing, washed, and analysed by protein blotting. Equal recovery of Gst fusion proteins from the precipitation reactions was veri®ed by electrophoresing 1/5 of the precipitate in 14% SDS-polyacrylamide gels and staining with Coomassie Brilliant Blue.
